The correlation of a positive DNA HPV HR test and genotyping human papilloma viruses with the presence of CIN, in women with cytologic evidence of ASC-US and LSIL;Korelacja pozytywnego wyniku testu na DNA HPV HR oraz genotypowania wirusów brodawczaka ludzkiego z obecnościa CIN u kobiet z rozpoznaniem cytologicznym ASC-US i LSIL

Ginekologia Polska

Volumn 79, Issue 7, 2008, Pages 490-493

  Bedziński, Maciej ^a   Józefiak, Agata ^b   Szczepańska, Małgorzata ^d   Pruski, Dominik ^b,c   Kedzia, Witold ^b,c   Spaczyński, Marek ^c  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b GPSK ^*  (Poland)

^c Klinika Onkologii Ginekologicznej   (Poland)

^d Klinika Rozrodczo ci   (Poland)

Author keywords

ASC US atypical squamous cells of undetermined significance; Human papilloma virus; LSIL low squamous intraepithelial lesion; Molecular test

Indexed keywords

EID: 54149117819     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kotarski J, Kedzia W. Zasady wykorzystywania diagnostyki molekularnej identyfikujacej DNA onkogennych typów HPV w wykrywaniu śódnabłonkowej neoplazji szyjki macicy. Ginekologia po Dyplomie. 2007, 9, 49-55.
2. Spaczyński M, Nowak-Markwitz E, Kedzia W. Skrining raka szyjki macicy w kraju i na świecie. Ginekol Pol. 2007. 5, 354-360.
3. Wright J, Rader J, Davila R, [et al.]. Human papillomavirus triage for young women with atypical squamous cells of undetermined significance. Obstet Gynecol. 2006, 107, 822-829.
4. Cuzick J, Szarewski A, Cubie H, [et al.]. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet. 2003, 362, 1871-1876
5. Polskie Towarzystwo Ginekologiczne. Rekomendacje PTG dotyczace diagnostyki, profilaktyki i wczesnego wykrywania raka szyjki macicy. Ginekol Pol. 2006, 77, 655-659.
6. Kauffman R, Adam E, Icenogle J, [et al.]. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol. 1997, 4, 930-936.
7. Ronco G, Cuzick J, Segnan N, [et al.]. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer. 2007, 43, 476-480.
8. Kirby T, Warner K. HPV Triage of patients with ASCUS cervical Pap smears. Sexuality, Reproduction and Menopause. 2004, 3, 146-153.
9. Manos M, Kinney W, Hurley L, [et al.]. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999, 281, 1605-1610.
10. Wright T, Schiffman M, Solomon D, [et al.]. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004, 103, 304-309.